Bhubaneswar: The Drugs Controller General of India (DCGI) on Thursday granted conditional market approval for COVID-19 vaccines, Covishield and Covaxin, for use in adult population with certain conditions.
The vaccines, however, will not be available at medical stores. Hospitals and clinics can purchase the vaccines.
The approval has been granted under the New Drugs and Clinical Trials Rules, 2019.
The price of these vaccines of Serum Institute of India and Bharat Biotech is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, the PTI reported quoting official sources.
Both the vaccines are currently only authorised for emergency use in India. While Covaxin is priced at Rs 1,200 per dose, Covishield costs Rs 780 at private facilities.
Sambalpur: Police have arrested one person in connection with alleged torture of the inmates of… Read More
Mumbai: The casting for the fifth instalment of Raghava Lawrence’s horror comedy franchise ‘Kanchana' is… Read More
New Delhi: The Ministry of Finance has invited applications for the post of Chairperson for… Read More
Bhadrak: The relatives of a woman, who died after childbirth, allegedly ransacked a private nursing… Read More
Prayagraj: The appointment of former Bollywood actress Mamta Kulkarni as the Mahamandaleshwar of the Kinnar… Read More
Mumbai: Amid reported death threats allegedly originating from Pakistan, choreographer-filmmaker Remo D’Souza recently attended the… Read More
This website uses cookies.
